- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00256529
Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
December 12, 2014 updated by: Kathryn A. Peterson, University of Utah
This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis (EoE) and to establish which presenting factors warrant esophageal biopsies.
We hypothesize that a greater than expected percentage of patients who are biopsies will have histologic changes consistent with EE.
Study Overview
Detailed Description
All patients presenting with dysphagia who do not already carry a previous diagnosis for their dysphagia will be asked to enroll.
If patients have undergone previous work up for dysphagia such as manometry, 24-hour probe, or barium swallow they can still participate in this study.
Informed consent will take place prior to enrollment.
After patients present with dysphagia they will fill-out a questionnaire regarding their dysphagia symptoms.
An EGD with biopsies will then be performed.
Biopsies will be taken from 4 quadrants in the proximal and distal esophagus.
The distal esophagus biopsies will be taken 5 cm proximal to the Z-line.
Proximal biopsies will be taken anywhere proximal to 30 cm from the incisors.
Study Type
Observational
Enrollment (Actual)
483
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84148
- Department of Veterans Affairs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients presenting with dysphagia will be eligibile for enrollment into the study.
Description
Inclusion Criteria:
- Patients aged 18-90 presenting with dysphagia or food impaction
- Ability to undergo esophagogastroduodenoscopy and biopsies
- No significant cardiopulmonary disease, or other contraindication to EGD
Exclusion Criteria:
- Contradiction to EGD and/or biopsies such as Boerhaave's syndrome, or history or bleeding disorder or elevated INR
- Inability to provide informed consent
- Esophageal varices
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
I
All subjects presenting in with dysphagia will be in this cohort.
|
All subjects presenting with dysphagia will undergo an EGD with distal and proximal biopsies of the esophagus.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess the percentage of patients who present with dysphagia who have EE by histologic criteria
Time Frame: December 2010
|
December 2010
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess the demographics of the EE patients with dysphagia
Time Frame: December 2010
|
December 2010
|
To measure the frequency, severity, and time course of dysphagia in patients with EE
Time Frame: December 2010
|
December 2010
|
To assess percentage of EE patients with recurrent, versus acute dysphagia
Time Frame: December 2010
|
December 2010
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kathryn Byrne, M.D., University of Utah
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
November 17, 2005
First Submitted That Met QC Criteria
November 17, 2005
First Posted (Estimate)
November 21, 2005
Study Record Updates
Last Update Posted (Estimate)
December 15, 2014
Last Update Submitted That Met QC Criteria
December 12, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Immune System Diseases
- Hypersensitivity, Immediate
- Hematologic Diseases
- Gastrointestinal Diseases
- Gastroenteritis
- Pharyngeal Diseases
- Otorhinolaryngologic Diseases
- Hypersensitivity
- Esophageal Diseases
- Leukocyte Disorders
- Eosinophilia
- Deglutition Disorders
- Eosinophilic Esophagitis
- Esophagitis
Other Study ID Numbers
- 14543
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophagitis
-
Yvonne RomeroBausch Health Americas, Inc.CompletedErosive EsophagitisUnited States
-
AstraZenecaCompletedRepeatedly Recurring Esophagitis | Relapsing Reflux EsophagitisJapan
-
Mayo ClinicCompletedGERD | Erosive Esophagitis | Reflux EsophagitisUnited States
-
TakedaRecruitingA Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in ChildrenErosive EsophagitisUnited States, Lithuania, Mexico, Canada, Colombia, Poland
-
Jiangsu Carephar Pharmaceutical Co., Ltd.CompletedErosive EsophagitisUnited States
-
TakedaCompletedErosive EsophagitisJapan
-
TakedaCompletedErosive EsophagitisChina, Taiwan, Korea, Republic of, Malaysia
-
TakedaTerminatedErosive EsophagitisChina
-
Chang Gung Memorial HospitalCompleted
-
HK inno.N CorporationCompletedErosive EsophagitisKorea, Republic of
Clinical Trials on EGD with biopsies
-
Vanderbilt UniversityCompletedGastroesophageal Reflux | Larynx DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnGastro Esophageal Reflux Disease PPI Non-Responders
-
Mayo ClinicNational Cancer Institute (NCI); Northwestern University; National Institute...CompletedPancreatic CancerUnited States
-
NinePoint MedicalUnknownBarrett's EsophagusUnited States
-
Institute for Clinical and Experimental MedicineCompleted
-
Stanford UniversityThe University of Texas Health Science Center, Houston; University of RochesterTerminatedCholangiocarcinoma | Stricture; Bile DuctUnited States
-
Vanderbilt University Medical CenterCompletedGastroesophageal Reflux Disease (GERD) | Non-erosive Reflux Disease (NERD)United States
-
Nantes University HospitalUnknown
-
NYU Langone HealthCompletedChronic Cough (CC) | Gastroesophageal Reflux (GER)United States
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedFunctional Dyspepsia | Gastroesophageal Reflux Disease (GERD) | Eosinophilic Esophagitis (EoE)United States